Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Cover image for Vol. 32 Issue 2

February 2012

Volume 32, Issue 2

Pages 99–190, e17–e44

  1. Editorial

    1. Top of page
    2. Editorial
    3. Special Article
    4. Original Research Articles
    5. Brief Report
    6. Reviews of Therapeutics
    7. Case Reports
    8. ACCP Commentary
    1. You have free access to this content
  2. Special Article

    1. Top of page
    2. Editorial
    3. Special Article
    4. Original Research Articles
    5. Brief Report
    6. Reviews of Therapeutics
    7. Case Reports
    8. ACCP Commentary
    1. On Pharmacogenomics in Pharmacy Benefit Management (pages 103–111)

      J. Russell Teagarden and Eric J. Stanek

      Version of Record online: 24 JAN 2012 | DOI: 10.1002/PHAR.1039

  3. Original Research Articles

    1. Top of page
    2. Editorial
    3. Special Article
    4. Original Research Articles
    5. Brief Report
    6. Reviews of Therapeutics
    7. Case Reports
    8. ACCP Commentary
    1. Economic Analysis of Alvimopan for Prevention and Management of Postoperative Ileus (pages 120–128)

      Daniel R. Touchette, Yoojung Yang, Funda Tiryaki and William L. Galanter

      Version of Record online: 24 JAN 2012 | DOI: 10.1002/PHAR.1047

    2. A Real-World Evaluation of Oral Vancomycin for Severe Clostridium difficile Infection: Implications for Antibiotic Stewardship Programs (pages 129–134)

      Frank Le, Vaneet Arora, Dhara N. Shah, Miguel Salazar, Hannah R. Palmer and Kevin W. Garey

      Version of Record online: 24 JAN 2012 | DOI: 10.1002/PHAR.1002

    3. Prescription Ergocalciferol Dosing for Vitamin D Repletion: A Retrospective Evaluation (pages 135–141)

      Joseph P. Vande Griend, Robert B. McQueen, Sunny A. Linnebur and Sheryl F. Vondracek

      Version of Record online: 30 JAN 2012 | DOI: 10.1002/PHAR.1052

  4. Brief Report

    1. Top of page
    2. Editorial
    3. Special Article
    4. Original Research Articles
    5. Brief Report
    6. Reviews of Therapeutics
    7. Case Reports
    8. ACCP Commentary
  5. Reviews of Therapeutics

    1. Top of page
    2. Editorial
    3. Special Article
    4. Original Research Articles
    5. Brief Report
    6. Reviews of Therapeutics
    7. Case Reports
    8. ACCP Commentary
    1. Boceprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C (pages 173–190)

      Olga M. Klibanov, Stephen B. Vickery, Jacqueline L. Olin, Lisa S. Smith and Shannon H. Williams

      Version of Record online: 30 JAN 2012 | DOI: 10.1002/PHAR.1046

  6. Case Reports

    1. Top of page
    2. Editorial
    3. Special Article
    4. Original Research Articles
    5. Brief Report
    6. Reviews of Therapeutics
    7. Case Reports
    8. ACCP Commentary
    1. Prasugrel as a Safe Alternative for Clopidogrel-Induced Polyarthralgias (pages e24–e26)

      Chad J. Coulter and Shari V. Montandon

      Version of Record online: 24 JAN 2012 | DOI: 10.1002/PHAR.1044

    2. Irreversible Atorvastatin-Associated Hearing Loss (pages e27–e34)

      Michael Liu, Antonia Alafris, Anthony J. Longo and Henry Cohen

      Version of Record online: 24 JAN 2012 | DOI: 10.1002/PHAR.1040

  7. ACCP Commentary

    1. Top of page
    2. Editorial
    3. Special Article
    4. Original Research Articles
    5. Brief Report
    6. Reviews of Therapeutics
    7. Case Reports
    8. ACCP Commentary
    1. You have free access to this content
      Acute Care Clinical Pharmacy Practice: Unit- versus Service-Based Models (pages e35–e44)

      Curtis E. Haas, Stephen Eckel, Sally Arif, Paul M. Beringer, Elizabeth W. Blake, Allison B. Lardieri, Bob L. Lobo, Jessica M. Mercer, Pamela Moye, Patricia L. Orlando and Kurt Wargo

      Version of Record online: 30 JAN 2012 | DOI: 10.1002/PHAR.1042

SEARCH

SEARCH BY CITATION